JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC
Trial Details
- NCT ID
- NCT02468024
- Phase
- PHASE3
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Cancer Type
- Lung Cancer
- Interventions
- Lung Surgery
- Radiation therapy
- Locations (sample)
- La Jolla, California, United States|32.84727,-117.2742
- Aurora, Colorado, United States|39.72943,-104.83192
- Colorado Springs, Colorado, United States|38.83388,-104.82136
- Boca Raton, Florida, United States|26.35869,-80.0831
- Savannah, Georgia, United States|32.08354,-81.09983
Key Eligibility Criteria
- 1 Age \> 18 years.
- 2 ECOG/Zubrod performance status (PS) 0, 1, or 2 (reference Appendix C).
- 3 Radiographic findings consistent with non-small cell lung cancer, including lesions with ground glass opacities with a solid component of 50% or …
- 4 The primary tumor in the lung must be biopsy confirmed non-small cell lung cancer within 180 days prior to randomization.
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Lung Cancer Trials on Trialify →